ABSTRACT
INTRODUCTION
Craniopharyngiomas are the most common type of intracranial tumors of non-glial origin in the pediatric population and account for 6-9% of brain tumors. 1 Their incidence reaches its peak between 5 and 10 years old but may occur at any age.
These are histologically benign embryonic malformations derived from the ectoblastic remnants of the Rathke's pouch between the pituitary and hypothalamus, and may affect key hormone secretion for endocrine regulation and satiety modulation. 2 Although this is a benign tumor and the survival rate of this disease is high, it is notably associated with morbidities, even if completely resected, 3, 4 especially severe obesity, which is generally refractory to treatment.
Childhood obesity, particularly with visceral fat distribution and regardless of its etiology, results in major complications, including insulin resistance, type 2 diabetes, hypertension, and cardiovascular disease, etc. [5] [6] [7] [8] A recent study 9 found, during the longitudinal follow-up of patients after craniopharyngioma surgery, that obesity at the time of diagnosis was a predictor of obesity at 5 years after resection. This may support hypothalamic involvement as the main risk factor for obesity in these patients. 10 In addition, insulin resistance measured using the homeostasis assessment model (HOMA) before the surgery correlates to post-operative weight gain. 11, 12 Although this is a relatively benign disease, the combination of severe hypothalamic obesity and associated comorbidities results in a reduced quality of life. 13 Based on the preceding concepts, we proposed to study the presence of obesity and metabolic complications in a cohort of patients under follow- 17 Baseline energy expenditure was recorded using an indirect calorimetry measuring O 2 consumption and CO 2 production (CCM Express, MEDGRAPHICS) for 20 minutes after 20 minutes at rest.
Energy intake and energy distribution of macronutrients were assessed prospectively using a 3-day diet registry specially designed for this study. The sample registry sheet is attached (see Annex).
Date and age at the time of the surgery, radiation requirement, hormone replacement, antiepileptic and psychiatric drug use after the surgery were recorded.
Statistical analysis
The statistical software package used was STATA/SE11. Each outcome measure behavior was analyzed and reported as mean/SD for normal outcome measures or as median/range for those with a biased distribution. Student's t test and the Wilcoxon rank-sum test were used for normal and biased distribution outcome measures, respectively. Categorical outcome measures were analyzed using the χ²/Fisher test. A two-tailed test and a statistical significance of p < 0.05 were assumed.
RESULTS
The accessible population was made up of 70 patients. Fifty-seven families were contacted on the telephone or by mail. Of these, 11 patients had died in the long-term post-operative period and 7 did not attend the scheduled visit. In the end, the percentage of the accessible population included in the research (sample) was 55% (39 patients). Of them, 54% were girls. Patients' median age was 12.2 years old (2.5-19.1 years old), and the median time elapsed between the surgery and the assessment was 4.6 years (0.19-11.8 years).
Summary and dispersion statistics of demographic and clinical outcome measures corresponding to the studied population are described in Table 1 .
As per the anthropometric nutritional assessment, 41% (16/39) of patients had a normal weight and 59% (23/39) were obese. No patient was categorized as overweight, so the analysis was done considering normal weight and obese subjects. As per waist circumference, 68% of patients had a central fat distribution. Ten patients (25%) had a low height/age.
Only one patient had HTN on the day of the assessment and was referred for follow-up. An abdominal ultrasound was scheduled for 12/39 patients; 50% had hepatic steatosis.
Biochemical outcome measures are shown in Table 2 . All patients had a normal blood glucose level. Forty percent of patients had insulin resistance as per the HOMA. In addition, 12 patients (32%) had dyslipemia (hypo-HDL and/or hypertriglyceridemia). Table 3 describes body composition and energy expenditure outcome measured in the studied population.
The mean energy intake was 1993 ± 658 daily calories (1708-2277 calories/day). The distribution of the percentage of energy from macronutrients was 40.4% (9.8-60%) from carbohydrates, 16.1% (10.6-38.2%) from proteins, and 43% (19-57%) from fat.
Radiotherapy had been used as adjuvant treatment in 23% (9/39) of patients. Endocrine d i s o r d e r s w e r e o b s e r v e d i n t h e f o r m o f panhypopituitarism in 95% of patients, for which replacement therapy with levothyroxine, desmopressin, and hydrocortisone was used. Growth hormone had been administered to 41% of patients. Among boys, 38% received testosterone. Anticonvulsant agents were required by 25%, and two patients were on risperidone due to behavior disorders. Among all assessed patients, only one reported he was not properly taking his medication so he was referred for multidisciplinary follow-up.
Afterward, the patient population was analyzed for the presence or absence of obesity: BMI Z-score of 3.7 (2 to 7.7) versus 1.23 (-1.69 to 1.92), p < 0.01, respectively. No significant differences were observed in the age of patients with a normal BMI versus obese patients (13.5 ±4.4 years old versus 10 ± 4.9 years old; p= 0.08).
Fifteen patients (38%) were younger than 6 years old at the time of the surgery. BMI Z-score among patients younger than 6 years old was higher than among older patients; however, no statistical significance was achieved (BMI Z-score of 3.1 ± 1.99 versus 2.2 ± 2, p = 0.17).
In relation to the scale of obesity as per the presence or absence of diabetes insipidus, in our population it was observed that patients with this morbidity (35/39) after the surgery had a BMI Z-score of 2.7 ± 0.33 versus 0.4 ± 0.04 in those who did not require treatment with desmopressin (3/39); the difference was not statistically significant (p= 0.06). The waist circumference was significantly smaller in the subgroup with a normal BMI (76.6 ± 13.1 versus 96.8 ± 23, p < 0.01). W h e n t h e o u t c o m e m e a s u r e w a i s t circumference was categorized as per the cutoff point, 31% (5/16) and 82% (19/23) of patients with a history of craniopharyngioma and with a normal BMI or obesity, respectively, had centralized fat mass (Fisher < 0.01). No significant differences were observed in the presence of insulin resistance (Fisher= 0.08), dyslipemia (Fisher= 0.46), or steatosis (Fisher= 0.54) between both groups.
No significant differences were observed in any of the studied biochemical outcome measures in both patient subgroups. Table 4 describes the body composition and energy expenditure outcome measures. No significant differences were observed in terms of energy expenditure at rest (EER) between patients with a normal BMI and obesity whereas, by definition, obese patients had a higher fat mass.
Then, tertiles were established by percentage of EER in the population of obese patients and the first tertile (82% of the predicted EER) was assumed as the cut-off point to categorize a normal versus a low EER. Among obese patients, 77% had a low energy expenditure.
A b i v a r i a t e a n a l y s i s w a s d o n e o f t h e percentage of lean body mass in the obese population based on a normal versus low EER and no significant differences were observed in the percentage of lean body mass between both groups (percentage of lean body mass: 62 ± 2.7 with a normal EER versus 61.2 ± 1.8 with a low EER; p= 0.8).
In relation to energy intake, no statistically significant difference was observed between patients with a normal BMI versus those with obesity (2225 versus 1814 calories, p= 0.15). An increased energy consumption from fat was detected in patients with a history of craniopharyngioma and a normal BMI compared to obese ones (46.5% versus 37.8%, p= 0.04).
DISCUSSION
Fifty-nine percent of patients (23/39) were obese. In relation to metabolic complications, 40% of patients had insulin resistance as measured by HOMA; 32% had dyslipemia (hypo-HDL and/or hypertriglyceridemia); and 50% of patients with an abdominal ultrasound had fatty liver.
When the population of patients was analyzed in terms of presence or absence of obesity, no significant differences were observed in relation to age. Obese patients had a higher level of central fat mass distribution than normal-weight ones, and no differences were observed in relation to metabolic complications in both groups.
Also, no significant differences were observed in terms of EER between normal BMI and obese patients. Among obese patients, 77% had a low energy expenditure. No significant differences were found in the percentage of lean body mass in the obese population in terms of normal versus low EER. Energy intake was similar between normal weight and obese patients.
A recent study confirms that mortality among patients with a history of craniopharyngioma, especially during childhood and accompanied by hypopituitarism, is greater than in the general population. 18 According to different studies, mortality caused by cardiovascular disease is 3 to 19 times higher compared to the general population. 19 The scale of obesity and the proportion observed in our study is consistent with that described by several authors: between 22% and 75%. [20] [21] [22] [23] A r e c e n t s t u d y ( i n p r e s s ) f o u n d t h a t the population with a history of childhood craniopharyngioma before 6 years old gained weight faster and had a greater scale of obesity compared to patients older than 6 years old (BMI Z-score: 3.8 ± 1.3 versus 2.7 ± 0.6, respectively). 24 In our study, no statistically significant differences were observed in the scale of obesity between patients who were diagnosed and had the surgery before and after turning 6 years old. Hypothalamic involvement before the surgery is associated with developing obesity after the surgery, 25 as adjusted by sex, age, and BMI at the time of the surgery, presence of hydrocephalus and residual tumor. Thus, it was also observed that diabetes insipidus acted as an endocrine marker of risk for hypothalamic obesity. 12 On the contrary, in our study, no statistically significant differences were observed in the scale of obesity between patients with and without diabetes insipidus. However, the difference in the BMI Z-score was overwhelming: 64% of patients with diabetes insipidus were obese whereas all those without this condition had a normal weight. Probably, the small size of the sample of patients without hypopituitarism hindered the possibility of finding differences between both populations.
In terms of low height frequency, a recently published study by Kalina et al. 26 conducted in 22 patients with a history of craniopharyngioma with follow-up for 5 years observed that 40% had a low height; in our study, however, the rate of low height was 25%. Such difference, in spite of the similar mean follow-up period, may be explained by the fact that our patients were assessed in a range of 0.19 to 11.8 years after the surgery, which may have underestimated the presence of low height that could be observed over a longer follow-up period.
Also, 40% of studied patients had insulin resistance, and 32% had dyslipemia, which is consistent with other authors who observed a frequency of 30% and 39%, respectively. 27 However, in the above-mentioned study by Kalina et al., the prevalence of metabolic disorders was higher: 68.2% of patients had insulin resistance and 86%, dyslipemia. Such difference may be explained by the fact that their population had a higher obesity prevalence than ours (81.8% versus 59%) and, therefore, a higher risk for metabolic complications.
No significant differences were observed in the presence of insulin resistance once patients were categorized by BMI, although obese patients had a higher level of central fat mass distribution. There is no consensus in relation to such metabolic complication in the literature. In another study conducted by our team 28 that compared obese patients with a history of craniopharyngioma to a group of 43 patients with obesity of multifactorial etiology paired by sex and age found no significant differences in the scale of obesity, centralized fat mass by waist circumference, insulin resistance (52% versus 68%, p= 0.2), dyslipemia (p= 0.68), or hepatic steatosis (p= 0.34) between both groups.
Similarly to what was described in the study by Sahakitrungruang et al., 29 our study found that 50% of patients had fatty liver as observed in the abdominal ultrasound.
A recent study confirms that mortality among patients with a history of craniopharyngioma, especially during childhood and accompanied by hypopituitarism, is greater than in the general population. 18 According to different studies, mortality caused by cardiovascular disease in these patients is 3 to 19 times higher compared to the general population. 30 Body composition was similar in terms of percentage; however, once BMI was categorized, patients with a normal BMI had a higher percentage of lean body mass and a lower percentage of fat body mass than their obese peers. In the above-mentioned study, 30 obese patients with a history of craniopharyngioma had a lower percentage of lean body mass and a higher percentage of fat body mass compared to those with obesity of multifactorial etiology, and a lower and statistically significant EER (1297 ± 586 versus 1721 ± 469, p < 0.01), regardless of their lean body mass.
No statistically significant differences were found in this study in relation to EER between normal weight and obese patients. In addition, 77% of obese patients had a low EER, which is consistent with previous publications. 31 Besides, a low EER persisted regardless of the lean body mass percentage, which supports the fact that there may be other factors that reduce energy expenditure in this group of patients.
Lastly, in relation to energy intake, no significant differences were found in patients with craniopharyngioma as per BMI, similar to what was reported in previous publications, 32 which concluded that, once hypothalamic obesity occurs, it remains over time regardless of hyperphagia, probably due to the reduced energy expenditure. Hoffmann et al. compared eating behavior among patients with a history of craniopharyngioma and patients with obesity of multifactorial etiology, and no significant differences were observed between both groups. 20 This study poses the following limitations: 1) the impossibility of contacting all patients who met the inclusion criteria due to missing personal data, especially those who had had the surgery a long time before; 2) the lack of a Tanner stage assessment; 3) the scarce number of patients categorized into the subgroups. Also, this study poses the following strengths: 1) the successful analysis of the entire accessible population of patients who had a craniopharyngioma surgery and were younger than 21 years old seen at the most relevant hospital for this disease at a national level; and 2) the prospective nature of the anthropometric and biochemical control, body composition, and EER of all studied patients.
CONCLUSIONS
In total, 59% of the population of patients with a history of craniopharyngioma were obese. Although obese patients were more likely to have a central fat mass distribution, no significant differences were observed between both groups in terms of metabolic complications.
A lower energy expenditure not related to lean body mass and a similar energy intake were observed among patients with a history of craniopharyngioma regardless of their BMI.
Based on the predictable course of patients with craniopharyngioma, emphasis should be made on the need for an early intervention in order to prevent an increased weight gain. n
